Assignee
INDEVUS PHARMACEUTICALS INC
US13 patents
Top patents by PatentIndex Score
US7452868B2Nov 18, 2008
Controlled release formulations of octreotide
INDEVUS PHARMACEUTICALS INC64 citations94
US7842303B2Nov 30, 2010
Long term drug delivery devices with polyurethane based polymers and their manufacture
INDEVUS PHARMACEUTICALS INC27 citations91
US6855721B1Feb 15, 2005
Methods and compositions for alleviating stuttering
INDEVUS PHARMACEUTICALS INC5 citations70
US6974835B2Dec 13, 2005
Methods for decreasing cell proliferation based on (3r,4r)-Δ8-tetrahydrocannabinol-11-oic acids
INDEVUS PHARMACEUTICALS INC9 citations69
US7057047B2Jun 6, 2006
Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2oxo-hexyl)-1-isoidolinone
INDEVUS PHARMACEUTICALS INC4 citations58
US6949653B2Sep 27, 2005
Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
INDEVUS PHARMACEUTICALS INC2 citations58
US7553847B2Jun 30, 2009
Use of pagoclone for the treatment of social anxiety disorder
INDEVUS PHARMACEUTICALS INC2 citations53
US7026332B2Apr 11, 2006
Methods of treating obsessive-compulsive disorder
INDEVUS PHARMACEUTICALS INC3 citations53
US6914072B2Jul 5, 2005
Cannabinoid drugs
INDEVUS PHARMACEUTICALS INC3 citations53
US6953670B2Oct 11, 2005
Methods for identifying compounds capable of supplementing the biological activity of leptin
INDEVUS PHARMACEUTICALS INC0 citations51
US6838079B2Jan 4, 2005
Methods for using the obese product to stimulate hematopoietic development
INDEVUS PHARMACEUTICALS INC0 citations51
US6524806B1Feb 25, 2003
Methods of screening for ligands of human hemetopoietin receptor HU-B1.219
INDEVUS PHARMACEUTICALS INC0 citations51
US7304158B2Dec 4, 2007
Method for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone)
INDEVUS PHARMACEUTICALS INC0 citations48